1 |
Wilson DC, Smith NA, Blakey NC, et al., Using researchbased knowledge to underpin waste and resources policy. Waste Manage Res 2007; 25: 247-56.
DOI
|
2 |
van Kammen J, de Savigny D, Sewankambo, et al., Using knowledge brokering to promote evidence-based policy-making: The need for support structures. Bulletin of the World Health Organization 2006; 84: 608-12.
DOI
|
3 |
Department of Health. Policy research programme: purpose, objectives and priorities. London: Department of Health, 2008.
|
4 |
Soumerai SB, Ross-Degnan D, Fortess, EE, et al., Determinants of change in Medicaid pharmaceutical cost sharing: does evidence affect policy? Milbank Quarterly 2007; 75: 11-34.
|
5 |
Cho JG, Lee EK, Kim JY, et al., Evaluation and policy implication of the Separation of prescribing and dispensing drugs. Seoul: Korea Institute for Health and Social Affairs, 2001.
|
6 |
Cho JG, Kim JY, Jang SM, et al., Monitoring health care utilisation behaviour after the inception of the separation of prescribing and dispensing drugs. Seoul: Korea Institute for Health and Social Affairs, 2002.
|
7 |
Jang SM, Lee EK, Kim Y, et al., Pharmaceutical utilisation before and after the separation of prescribing and dispensing of drugs; focusing on changes in prescribing behaviour. Seoul: Korea Institute for Health and Social Affairs, 2001.
|
8 |
Lee EK, Malone DC. Comparison of peptic-ulcer drug use and expenditures before and after the implementation of a government policy to separate prescribing and dispensing practices in South Korea. Clin Ther 2003; 25: 578-92.
DOI
|
9 |
Lee IH, Bloor K, Hewitt C, et al., The effects of new pricing and copayment schemes for pharmaceuticals in South Korea. Health Policy 2012; 104: 40-9.
DOI
|
10 |
Healy, D. The new medical oikumene. In: Petryna A, Lakoff A, Kleinman A, eds., Global pharmaceuticals: ethics, markets, practices. London: Duke University Press, 2006.
|
11 |
Lovell, A. M. Addiction markets: the case of high-dose buprenorphine in France. In: Petryna A, Lakoff A, Kleinman A, eds., Global pharmaceuticals: ethics, markets, practices. London: Duke University Press, 2006.
|
12 |
Jacobzone, S. Pharmaceutical policies in OECD countries: reconciling social and industrial goals. Paris: Organisation for Economic Co-operation and Development, 2000.
|
13 |
Denscombe, M. Surveys. The good research guide for small-scale social research projects. 3rd ed. Open University Press. Maidenhead. p7-34, 2007.
|
14 |
Patton, M. Q. Designing qualitative studies. Qualitative evaluation and research methods. 2nd ed. SAGE Publications Ltd. London. p143-98, 1990.
|
15 |
Guest G, Bunce A, Johnson L. How many interviews are enough? An experiment with data saturation and variability. Field Methods 2006; 18: 59-82.
DOI
|
16 |
Leech, NL. The role of sampling in qualitative research. Academic Exchange Quarterly. 2005; 9: 280-84.
|
17 |
Adamson J, Gooberman-Hill R, Woolhead G, et al., 'Questerviews': using questionnaires in qualitative interviews as a method of integrating qualitative and quantitative health services research. J Health Serv Res Policy 2004; 9: 139-45.
DOI
|
18 |
Marshall C, Rossman GB. Data collection methods. Designing qualitative research. 4th ed. Sage Publications Ltd. London. p97-150, 2006.
|
19 |
National Centre for Social Research. Framework; the qualitative data analysis tool. London: National Centre for Social Research, 2010.
|
20 |
Ritchie J, Spencer L. Qualitative data analysis for applied policy research. In: Bryman A, Burgess RG, eds., Analysing qualitative data. Routledge. London. p173-94, 1994.
|
21 |
Klein R. Learning from others: shall the last be the first? J Health Politics Policy Law 1997; 22: 1267-78.
|
22 |
Rose R. Introduction: why learn lessons from abroad? Learning from comparative public policy: a practical guide. Routledge. London, 2005.
|
23 |
Salter B. Doctors and managers. The new politics of medicine. Palgrave. Basingstoke. p68-92, 2004.
|
24 |
Harrison S, Wistow G. Managing health care: balancing interests and influence. In: Davey B, Popay J, eds., Dilemmas in health care. Buckingham: Open University Press, 1993.
|
25 |
Ameringer CF. Federal antitrust policy and physician discontent: defining moments in the struggle for congressional relief. J Health Politics Policy Law 2002; 27: 543-74.
DOI
|
26 |
DailyPharm. [Doctors' representatives, "stop the generic prescribing programme"]. DailyPharm. Seoul, 2007.
|
27 |
DailyPharm. [Medical academy doubts the quality of generic products]. DailyPharm. Seoul, 2007.
|
28 |
DailyPharm. [Head director of NMC Dr. Kang, "pharmacists would dispense profitable products under a generic prescribing programme]. DailyPharm. Seoul, 2007.
|
29 |
Danzon PM, Chao LW. Does regulation drive out competition in pharmaceutical markets? J Law Econ 2000; 43: 311-57.
DOI
|
30 |
Danzon PM, Furukawa MF. Prices and availability of pharmaceuticals: evidence from nine countries. Health Aff (Millwood) 2003; Suppl Web Exclusives: W3-521-36.
|
31 |
DongA IIbo. [US urged Korean government to give up the PERP]. Dong-A Ilbo. Seoul, 2006.
|
32 |
Guillen AM, Cabiedes L. Reforming pharmaceutical policies in the European Union: a "penguin effect"? Int J Health Serv 2003; 33: 1-28.
DOI
|
33 |
Lee SY, Kim YM. Globalization and independency of populist nations' welfare policies: focusing on the influences of multinational pharmaceutical companies on the Korean government's policy on the pharmaceutical industry. Korean J Social Welfare 2005; 57: 5-30.
|
34 |
Lee SY. The conflict between the protection of patents for pharmaceuticals under the TRIPS Agreement and the sovereign power to address domestic health crisis: a case study of Gleevec in South Korea. Korean J Social Welfare Studies 2004; 23: 139-67.
|
35 |
Cookson, R. Evidence-based policy making in health care: what it is and what it isn't. J Health Serv Res Policy 2005; 10: 118-21.
DOI
|
36 |
Innvaer S, Vist G, Trommald M, et al., A. Health policymakers' perceptions of their use of evidence: a systematic review. J Health Serv Res Policy 2002; 7: 239-44.
DOI
|
37 |
Choi BC, Pang T, Lin V, et al., Can scientists and policy makers work together? J Epidemiol Commun H 2005; 59: 632-7.
DOI
|
38 |
Sharpe M. Weighing the evidence: prospects for evidence-based policy-making. J Environ Monitor 2004; 6: 114N-17N.
DOI
|